EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Utilization of AhR and GPR35 Receptor Ligands as Superfoods in Cancer Prevention for Individuals with IBD

Olga Poźniak iD, Robert Sitarz iD, Monika Zofia Sitarz iD, Dorota Kowalczuk iD, Emilia Słoń iD, Ewa Dudzińska

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26189160 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Olga Poźniak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dietetics and Nutrition Education, Medical University of Lublin, 20-093 Lublin, Poland. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Receptors, Aryl Hydrocarbon, Receptors, G-Protein-Coupled, Colorectal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carcinogenesis is a complex process characterized by the uncontrolled proliferation of abnormal cells, influenced by environmental, genetic, and epigenetic factors. Chronic inflammation is undoubtedly one of the key contributors to carcinogenesis. Inflammatory bowel disease (IBD) is associated with an increased risk of colorectal cancer (CRC) due to persistent inflammation resulting from continuous immune system activation and excessive immune cell recruitment. IBD is also linked to certain nutritional deficiencies, primarily due to dietary modifications necessitated by the disease’s pathophysiology. Consequently, individualized nutritional supplementation appears to be a rational approach to addressing these deficiencies. The use of functional foods, including anti-inflammatory nutraceuticals, in individuals with IBD may play a crucial role in modulating cellular pathways that inhibit the release of inflammatory mediators. Thus, the regulation of the aryl hydrocarbon receptor (AhR) and G protein-coupled receptor 35 (GPR35) through dietary ligands appears to be of significant importance not only in the treatment of IBD and maintenance of remission but also in the prevention of tumorigenic transformation, particularly in genetically predisposed individuals. This narrative review was conducted using PubMed, Scopus, and Web of Science databases. The search covered literature published between January 2000 and June 2024. Keywords included ‘inflammatory bowel disease’, ‘colorectal cancer’, ‘AhR’, ‘aryl hydrocarbon receptor’, ‘GPR35’, ‘cytochrome P450’, ‘nutraceuticals’, ‘probiotics’, and ‘superfoods’. Only English-language articles were included. The selection focused on studies investigating mechanistic pathways and the role of dietary ligands in AhR and GPR35 activation in IBD and CRC. The SANRA guidelines for narrative reviews were followed to ensure transparency and minimize bias.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesReceptors, Aryl HydrocarbonReceptors, G-Protein-CoupledColorectal NeoplasmsHumansLigandsAnimalsDietary SupplementsBasic Helix-Loop-Helix Proteins

Stichwörter der Autor:innen

GPR35 receptoraryl hydrocarbon receptorchronic inflammationcolorectal cancercytochrome P450inflammatory bowel diseasetumorigenesis

Substanzen

Receptors, Aryl HydrocarbonReceptors, G-Protein-CoupledLigandsBasic Helix-Loop-Helix ProteinsAHR protein, human

Autor:innen und Institutionen

  • Department of Dietetics and Nutrition Education, Medical University of Lublin, 20-093 Lublin, Poland.
  • Department of Human Anatomy, Medical University of Lublin, 20-093 Lublin, Poland.
  • I Department of Surgical Oncology, St. John's Cancer Center, 20-090 Lublin, Poland.
  • Department of Conservative Dentistry with Endodontics, Medical University of Lublin, 20-090 Lublin, Poland.
  • Chair and Department of Medicinal Chemistry, Medical University of Lublin, 20-090 Lublin, Poland.

ORCID-Profile: Olga Poźniak, Robert Sitarz, Monika Zofia Sitarz, Dorota Kowalczuk, Emilia Słoń

Förderung

  • Medical University of Lublin

Zitieren

APA

Poźniak, O., Sitarz, R., Sitarz, M. Z., Kowalczuk, D., Słoń, E., & Dudzińska, E. (2025). Utilization of AhR and GPR35 Receptor Ligands as Superfoods in Cancer Prevention for Individuals with IBD. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26189160

Vancouver

Poźniak O, Sitarz R, Sitarz MZ, Kowalczuk D, Słoń E, Dudzińska E. Utilization of AhR and GPR35 Receptor Ligands as Superfoods in Cancer Prevention for Individuals with IBD. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26189160

BibTeX
@article{Poniak2025,
  author = {Poźniak, Olga and Sitarz, Robert and Sitarz, Monika Zofia and Kowalczuk, Dorota and Słoń, Emilia and Dudzińska, Ewa},
  title = {Utilization of AhR and GPR35 Receptor Ligands as Superfoods in Cancer Prevention for Individuals with IBD},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26189160}
}
Kostenlos starten →